ellipticine has been researched along with piperidines in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asseline, U; Bisagni, E; Hélène, C; Le Doan, T; Perrouault, L; Rivalle, C; Thuong, NT | 1 |
| Kumarasamy, VM; Sun, D | 1 |
| Adam, V; Arlt, VM; Heger, Z; Indra, R; Kolarik, M; Kopeckova, K; Stiborova, M | 1 |
3 other study(ies) available for ellipticine and piperidines
| Article | Year |
|---|---|
Recognition and photo-induced cleavage and cross-linking of nucleic acids by oligonucleotides covalently linked to ellipticine.
Topics: Base Sequence; Cross-Linking Reagents; DNA; Ellipticines; Hydrogen-Ion Concentration; Macromolecular Substances; Molecular Sequence Data; Molecular Structure; Oligonucleotides; Photochemistry; Piperidines; Temperature; Ultraviolet Rays | 1991 |
Demonstration of a potent RET transcriptional inhibitor for the treatment of medullary thyroid carcinoma based on an ellipticine derivative.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Carbazoles; Carcinoma, Neuroendocrine; Carcinoma, Papillary; Cell Proliferation; Ellipticines; G-Quadruplexes; Humans; Male; Mice; Mice, SCID; Piperidines; Proto-Oncogene Mas; Proto-Oncogene Proteins c-ret; Pyridines; Signal Transduction; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2017 |
Tyrosine kinase inhibitors vandetanib, lenvatinib and cabozantinib modulate oxidation of an anticancer agent ellipticine catalyzed by cytochromes P450 in vitro.
Topics: Anilides; Animals; Cytochrome P-450 Enzyme Inhibitors; Ellipticines; Humans; Microsomes, Liver; Oxidation-Reduction; Peroxidases; Phenylurea Compounds; Piperidines; Pyridines; Quinazolines; Quinolines; Rats | 2019 |